
Go Capital et al. in €5m round for Robocath
A consortium of previous and new investors has provided French medical robotics business Robocath with a €5m round of funding.
The fresh capital was provided by existing shareholders Go Capital, NCI, Normandie Participations, M Capital and Supernova Invest. They were joined by new backers Caisse d'Epargne Normandie Innovation, Crédit Agricole Innove en Normandie and Unexo.
Robocath will use this latest round to finance the rollout of its robotic platform in strategic European target markets. In conjunction with the round, the company also hired Lucien Goffart as CEO.
Previous funding
Go Capital and NCI led a €900,000 seed funding round for Robocath in May 2013, with the aim of strengthening the research and development team. Both VCs reinvested the same amount in July 2015, with €300,000 coming from NCI's Croissance et Proximité 2 fund and Go Capital making up the other €600,000.
VC firms M Capital and Normandie Participations then led a €4.7m funding round for the Rouen-based medical robotics startup in 2017. They were joined in the round by Go Capital and NCI.
Company
Established in 2009 and based in Rouen, Robocath is developing robots for remote arteriography. It is currently aiming for a commercial launch for its robotic platform R-One, for which it has received CE marking. The company employs a staff of 25.
People
Robocath – Lucien Goffart (CEO).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater